Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Regranex® (becaplermin) – Removal of warning
November 28, 2018 - The FDA approved the removal of the Boxed Warning and the warning in the Warnings and Precautions section of the Regranex (becaplemin) drug label regarding increased rate of mortality secondary to malignancy.
